Delve Bio
PrivateLast Round
Series A
Jun 20, 2023
Total Funding Raised
$35M
Company Overview
Delve Bio is a biotechnology company that provides a metagenomic next-generation sequencing (mNGS) platform for the unbiased detection of neuro-infectious pathogens in cerebrospinal fluid.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Delve Bio Comparables
Compare Delve Bio with similar companies based on industry and business-model similarity.
Delve Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 20, 2023 |
Delve Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| S32 | Series A |
| GV | Series A |
| Perceptive Advisors | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 23, 2026
Monthly visitors grew 83% MoM, reaching 7.2K.
- Jan 1, 2024
Flagship platform Delve Detect to launch in 2024.
Delve Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Delve Bio's valuation, stock price, and market status.
Is Delve Bio a public or private company?
Delve Bio is a private company.
What is the current stock price of Delve Bio?
Delve Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Delve Bio worth (valuation)?
Valuation information for Delve Bio is not publicly available.
Can I buy Delve Bio stock?
Delve Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Delve Bio's last funding round?
Delve Bio's most recent funding round was Series A on June 20, 2023.
Who are the main investors in Delve Bio?
Key investors in Delve Bio include Perceptive Advisors.
Will Delve Bio IPO soon?
No public IPO plans have been announced for Delve Bio.
How can I track Delve Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Delve Bio's secondary market activity and sign up for updates.